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Abstract: the presentation addresses the field of translating EU texts (directives), specifically the 
Medical Device Directive. The translation of EU instruments lies within the scope of 
responsibilities of the translators working for the European Commission and the European 
Parliament. Yet, sworn translators working in their native countries face the need to translate 
medical documentation both for natural persons (that is necessary for administrative purposes) and 
for corporate bodies (that operate on the common European market and require e.g., declarations 
of conformity, instructions for use or EC design examinations certificates to commercialise their 
products and thus run their business). Naturally, sworn translators while performing tasks 
commissioned refer to and consult the accepted translated versions of EU instruments to remain in 
line with the versions that have been transposed into their national legislations. In this paper, the 
original (English) and the translated (Polish) versions of the Medical Device Directive 
(93/42/EEC) shall be compared and analysed to find whether the Polish version fully reflects 
assumed terminological consistency.  
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TŁUMACZ PRZYSIGLY A DYREKTYWY: TERMINOLOGICZNE WYZWANIA 
ZWIZANE Z TŁUMACZENIEM DYREKTYWY DOTYCZCEJ WYROBÓW 
MEDYCZNYCH 
Abstrakt: Artykuł dotyczy przekładu tekstów zwizanych z Uni Europejsk (dyrektyw), w 
szczególnoci dyrektywy dotyczcej wyrobów medycznych. Tłumaczenie tekstów unijnych 
znajduje si w gestii tłumaczy pracujcych w Komisji Europejskiej i Parlamencie Europejskim. 
Tłumacze przysigli wiadczcy swoje usługi we własnym kraju musz si zmierzy z 
tłumaczeniem tekstów i dokumentacji medycznej zarówno dla osób fizycznych (co bywa 
konieczne dla celów administracyjnych) oraz dla osób prawnych i firm działajcych na wspólnym 
rynku europejskim, które do prowadzenia swojej działalnoci potrzebuj np. deklaracji zgodnoci, 
instrukcji uytkowania czy certyfikatów badania projektu WE w celu wprowadzenia produktów do 
obrotu). Tłumacze przysigli w trakcie realizowania zlece odwołuj si do zaakceptowanych 
wersji dokumentów UE, aby zachowa zgodno terminologiczn z wersjami 
przetransponowanymi do polskiego prawa. W artykule zostanie przeprowadzona analiza 
porównawcza oryginalnej (angielskiej) i przetłumaczonej (polskiej) wersji dyrektywy dotyczcej 
wyrobów medycznych (MDD, 93/42/EWG), która ma na celu zbadanie zgodnoci 
terminologicznej oryginału i przekładu.  
Słowa kluczowe: teksty unijne, dyrektywy, tłumaczenie tekstów medycznych, terminologia 
medyczna  
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Introduction 
The language of legal instruments, itself being a multi-faceted and an intriguing 
phenomenon, is, undoubtedly, a challenge for all translators, and sworn translators in 
particular, due to the rights and duties they possess. The European Union through its 
acquis communautaire effectively and clearly designates legal rights and duties of 
individuals, of social groups, of societies and of entire states. Thus legal instruments 
have an immense potential to influence human life.   
Translating EU texts is a truly challenging task, given high standards that are to be 
fulfilled in this area. Translators are not a party to the drafting process, yet their 
knowledge of the issues and terminology occurring in the texts they are to translate 
should be thorough. The aim of this paper is to briefly discuss the specificity of EU texts, 
with a special focus laid on one of medicine-related directives that embraces the most 
comprehensive range of medical devices, i.e., the Medical Device Directive, which shall 
be followed by the comparison of two versions of the Directive (the English original and 
its Polish  translation) in order to analyse the impact of terminological knowledge 
deficiencies on the final translation product and resultant far reaching consequences.  
EU texts 
It has to be borne in mind that the fact whether a given text, or a legal instrument, 
belongs to the category of legal texts does not rely on its linguistic features, regardless of 
their importance, but the major classification of legal texts sets the line between texts 
without the force of the law and normative ones, i.e. authoritative texts that are legally 
binding their addressees. Therefore an established and generated set of a variety of the 
sources of law in a given legal system determines the real legal nature of the text. The 
function of legal texts seems to be the most useful classification ‘tool’, and the debate 
pertaining to the fact whether legal texts display an informative function has been 
developing for years. Šarevi (2000, 11) enumerates three categories of legal texts: 1) 
primarily prescriptive, 2) primarily descriptive but also prescriptive, 3) purely 
descriptive (2000, 11). Primarily prescriptive texts embrace laws and regulations, codes, 
contracts, treaties and conventions (thus directives are also included within this 
category), and the normative nature is the common feature of those texts. The second 
category covers judicial decisions and instruments related to judicial or administrative 
proceedings (appeals, actions, petitions, pleadings); these texts are mainly descriptive. 
Prescriptive elements tend to have some legal force yet they are not sources of the law 
and they do not establish legal norms. Finally, purely descriptive texts refer to the 
doctrine in the form of legal opinions of law experts, scholars, law textbooks, and 
articles focusing on law-related issues.  
Directives, together with regulations and decisions, belong to secondary EU law 
that comprises legal acts and instruments as well as international agreements concluded 
by the European Union. Directives are published in the Official Journal of the European 
Communities and are generated either by the EU Council or the EU Commission. In 
contrast to regulations, they do not have equivalents in terms of the domestic legislation. 
They are also binding for a given member state within a specific field and specific 
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results that are to be achieved. The methods of attaining these results are left to each 
Member State’s discretion. 
EU normative texts (embracing the entire legal output and legal regulations of the 
European Union, i.e., acquis communautaire) are part of the working reality of sworn 
translators. Not only are translators obliged to observe them as citizens of a given 
member state of the European Union, but also to use them as a source of reference when 
needed. Obviously, sworn translators do not translate EU texts (it is the responsibility of 
the Directorate General for Translation), yet relevant terminology applied in those texts 
may be helpful in accomplishing tasks commissioned.  
Provisions of the EU law are currently published in all language versions (official 
languages) of the EU pursuant to Articles 21 and 290 of the Treaty Establishing the 
European Community (Jopek-Bosiacka 2006). The languages of member states can be 
classified into three groups, and these are: 
1. authentic languages of treaties that are identically legally valid and form the basis 
for binding interpretation of treaties 
2. official languages are all the official languages of the European Union member 
states 
3. working languages that are used on a daily (working) basis, i.e. English, French 
and German 
The English language used within the EU (and in EU documents) is considered 
somewhat different from standard English, which may be caused by a variety of factors. 
First of all, the EU legislation is not always produced and drafted by native speakers of 
English. Secondly, the supranational nature of normative legislation of the European 
Union enforces the application of directives and regulations that do not occur in legal 
systems of member states. Therefore we are witnessing some form of a reformulation of 
traditional, almost classic, concepts inherent for communicative contexts such as the 
sender and receiver of a message or a text type, as they become blurred or ambiguous. 
The emerging product is conceptually similar to what Trosborg called ‘hybrid text’ 
(Trosborg 1997? 146) as they are “documents produced in a supranational multicultural 
discourse community where there is no linguistically neutral ground”. This might be the 
reason why these texts are in a way ‘a-cultural’ in the sense of not having resulted from 
particular cultures and languages, but being ‘born’ on the intercultural plane and derived 
from the contact between cultures and languages. Koskinen (2000:59) aptly observes 
that the specificity of EU translations is “the blurred divisions of languages and cultures. 
It has been taken for granted in translation studies that a change of language always also 
entails a change of culture, but within the EU context many translations are in fact 
intracultural”.   
Thirdly, what is also typical of EU legal documents is certain standardisation of 
texts; the identity of content (meaning) was mentioned above, yet the very structure and 
organisation of the texts must be matching as well: articles, paragraphs, sentences, 
clauses, etc. are organised identically and the text is easier to follow in terms of finding 
references to other EU official language versions. Trosborg (1997, 152) mentions the full 
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stop rule which stipulates that the number of full stops both in the source text and its 
translations must be equal. In terms of terminology, the role of potential connotations of 
meaning is less essential: the referent is most important (thus the referential function 
prevails), and a specialist term is viewed in its conceptual context.  
The language of those documents is a specialist language, and has properties 
characteristic of specialist texts. Šarevi (2000) even considers this language a sub-
language that is subject to certain specific rules (of syntactic, pragmatic and semantic 
nature). Additionally, yet another feature is typical of the language of those texts, 
namely,  specialist vocabulary, whose aim is the accurate description of the reality 
affected by the normative function legal documents are intended to perform. Therefore, 
the text of a directive includes, apart from typical features of specialist texts such as 
(over)use of the passive, impersonal forms, nominalisations, and specialist vocabulary 
from a given field. The language of legal texts is, obviously, a challenge for translators: 
as a specialist language it has certain characteristic features (for further elaboration on 
such features as precision, vagueness, complexity, conservatism, and specialisation see 
Tiersma 1999). The reality in which legal texts function is described and reflected in 
specialist terminology: terms encountered in legal texts and those that refer to a given 
legal system can have a different meaning from their relevant correspondents in other 
legal systems due to the absence of an item, activity, or institution (Šarevi 2000). 
Naturally, all legal systems have their own legal realia or sets of concepts (quite 
frequently highly abstract ones), therefore it seems substantially difficult to compare 
terms used in different legal systems. These terms are defined (Šarevi 2000) as 
system-bound terms (also see de Groot (1999, 206) for Systemgebundenheit) because 
there are so deeply contextualised in a specific legal system. For that reason they are 
quite often untranslatable or their translation must be descriptive to compensate 
conceptual gaps. This conceptual incongruity in terminology (Šarevi 2000) may result 
from the historical evolution of legal systems that led to the development of a conceptual 
and terminological apparatus pertaining to social, historical, economic or cultural issues 
vital for a given country and its legal tradition. For this very reason – as Chiocchetti and 
Ralli (2013, 11-12) aptly observe – legal concepts are so difficult to be transposed from 
one legal system to another, which results in legal translation being a very complex task.   
Since the focus of our considerations in this paper is the language, and 
specifically specialist vocabulary, of the Medical Device Directive (93/42/EEC) and 
translation-related problems that occur in the Polish version of this instrument 
(henceforth MDD), a number of comments pertaining to the specificity of medical terms 
and challenges they pose for translators as well as the context in which medicine-related 
directives function seems in order. It is common knowledge that medical translation is 
one of the types of technical (specialist) translation that is concentrated on medicine and 
its related fields. First and foremost, due to its being conditioned by the ethical codes of 
both biomedical research and healthcare, it should be accurate and reliable (Resurreccio 
2011), as a translation error may result in serious consequences (for the discussion on 
quality of medical translation see Karwacka 2014). Thus the priority of the translator is 
to transfer not only the complex terminological content but also the form with features 
inherent in specialist translation; this transfer should be devoid of any references to 
cultural or ideological issues. Resurreccio (2007) claims that this neutrality and 
objectivity in conveying information gave rise to neutral, impersonal and uniform style 
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of medical translation. One of problems typical of the English medical language is the 
fact that medical terminology was constructed out of roots, prefixes and suffixes of Latin 
or Greek origin (for further elaboration see Kociałkowska-Okoska 2012; problems 
related with Greek and Latin roots and stems are discussed in van Hoof 1998). 
Resurreccio and Gonzalez (2007, 230-255) observe two major trends in medical 
terminology: one towards standardisation (in vitro terminology), the other towards 
variation (in vivo terminology). The aforementioned Greek and Latin forms and terms 
are – to a substantial extent – internationalised, and the emerging differences between 
modern languages are only in spelling. Standardisation pertains also to a variety of 
international classifications (e.g. the International Classification of Diseases or the 
Nonproprietary Names of Pharmaceutical Substances, cf. Resurreccio and Gonzalez 
2007), yet it must also consider the fact that medical terminology is in a state of flux, 
changing dynamically and embracing recent discoveries and innovations.  
Synonyms are yet another problem, and quite frequently they co-occur – as  
a ‘mixture’ of both ordinary and specialist language (so called doublets) – in e.g. hospital 
records or discharge reports. Equivalent names have been used for a variety of reasons, 
to mention only descriptive, historical or anatomical nature. Acute anterior poliomyelitis, 
formerly known as the Heine-Medin disease, might serve as an example of this trend: in 
the past it was translated into Polish as choroba Heine-Medina or choroba Heinego-
Medina. With the passage of time, it has been more regularly referred to as polio (an 
abridged form of poliomyelitis) which is a recognised international term for the disease. 
Terms adapted from names of physicians or scientists, i.e., eponyms, enhance the usage 
of synonyms. Van Hoof (1998) introduces a distinction between two types of eponyms, 
depending on whether the proper noun gives rise to another proper noun (e.g. 
parkinsonism/ parkinsonizm) or whether the proper noun refers to a disease (e.g. Down’s 
syndrome/ zespół Downa) or an anatomical notion (e.g. islets of Langerhans/ wysepki 
Langerhansa).   
Finally, another typical and problem-generating feature of medical texts is the 
presence of abbreviations (shortened forms of words or phrases, usually not capitalised) and 
acronyms (constructed out of word strings, usually capitalised), particularly in view of the 
multiplicity of potential meanings. They are frequently and commonly used in medical 
language to – as van Hoof (1998) claims – save time and space, and to make the language 
hermetic and understood by professionals only. Those acronyms and abbreviations are not 
usually explained in medical texts, constituting thus a part of a lexicon of medical 
professionals (cf. Kasprowicz 2010).  
The abovementioned problems related with medical language require from the 
translator a thorough insight not only into the text, but also into its context, in which the 
text is to function and be effective; this shall be briefly discussed in the following 
section.     
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Translating directives: the case of the Medical Device Directive  
At present, translation of documentation related with medical devices is a necessity since 
global healthcare market players tend to apply a number of requirements – to be fulfilled 
by translators – in proceeding with user documentation (such as e.g. instructions for use) 
and related materials. Obviously, these requirements may vary from country to country 
(depending on provisions and conditions imposed by, for instance in Poland, the Office 
for Registration of Medicinal Products, Medical Devices and Biocidal Products [Urzd 
Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych]). 
Within the European Union the process of commercialisation of medical devices is 
stipulated and specified in three directives, namely the aforementioned Medical Device 
Directive (MDD; 93/42/EEC), Active Implantable Medical Devices Directive (AIMD; 
90/385/EEC) and the In Vitro Diagnostic Medical Device Directive (IVDD; 98/79/EC); 
out of these three the MDD covers the widest range of procedures and products, and for 
that reason it was selected as exemplary for the analysis in this paper. As far as 
translation requirements pertaining to these directives are concerned, there is an 
extensive degree of similarity, yet – in line with general principles of the EU legislation 
– particular EU member states are capable to establish separate essential requirements 
for medical devices.  
MDD, AIMD or IVDD include dozens of medical or medicine-related words, and 
understanding them is absolutely essential for successful task performance, and the most 
essential priority of the translator is the most accurate transfer of the message included in 
the original text. The sworn translator encounters MDD (or other EU documents that 
refer to medicine or related disciplines) if research documentation – connected with the 
task commissioned – pertaining to a medicinal product or a medical device, i.e., the 
objective of the MDD, is to be made available to the general public (patients, doctors, 
experts), and products are to be launched on the market. If medicines or medical devices 
are to be commercialised, then – as the first step – legal requirements must be fulfilled, 
and the medicines or devices approved of by the Federal Drug Agency or the European 
Medicines Agency. The second step, as Poland is one of EU member states, entails the 
necessity to translate legal documents into Polish. As it was mentioned above, these 
documents are translated by translators within the European Commission and the 
European Parliament. However, outside the EC and EP context, sworn translators 
translate medical documentation not only for natural persons who need that for 
administrative purposes (e.g. death certificates, hospital records, discharge reports, 
examination results, etc.). They also translate texts for corporate bodies operating on the 
common European market. Product commercialisation procedures require such 
documents as, for instance, declarations of conformity, instructions for use (IFU), EC 
design examination certificates, full quality assurance certificates, product registration 
documents, patient information leaflets (PILs), or clinical trial protocols. In Poland, 
relevant provisions of the law require such documentation be translated only by sworn 
translators to be legally valid; this is where the sworn translator comes into the fore and 
in this very place can encounter a variety of potential problems. Obviously, it is hardly 
possible to mention all types of texts; the above short list shows, nevertheless,  how 
varied the tasks for sworn translators are and how demanding in terms of translation they 
can be.  
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The classification of medical devices in the abovementioned directives – from 
Class I to Class III – relies on the degree of risk related with the usage of these devices. 
Concurrently, requirements for translators are certainly more complex as medical 
devices belonging to Class I and Class II need to be accompanied by additional 
certificates, issued by third parties such as notified bodies and registered EU 
representatives.  
It should be stressed that manufacturers of medical devices and medical products 
need to have production-related documentation, including declarations of conformity, 
full quality assurance certificates, instructions for use, etc., translated in official 
languages of a given country where the commercialisation process takes place. The 
range of the product within the EU determines the range of languages into which the 
product documentation and supporting materials are to be translated. Thus translation 
even into all 24 official languages of the EU may be necessary for one product to comply 
with essential provisions of the MDD, AIMD or IVDD, which is a prerequisite to have 
the CE labelling.  
In this context the sworn translator faces a huge challenge. On the one hand, 
enterprises operating on broadly understood healthcare markets should consider potential 
benefits for the performance and success of their products resulting from good 
translation. On the other hand, wrong, inappropriate, low-quality or simply incompetent 
translation can ruin the reputation of an enterprise or even, which is far worse, do harm 
to the final user and, eventually, result in serious legal consequences. For instance, if 
certain items from the original version of the directive are omitted in translation – most 
probably due to the translator’s oversight, which per se is unacceptable – then the 
national legislation is to implement and use a slightly different version, and this stands in 
stark contrast with the principle of identity between documents, and related subordinate 
provisions may be also different and may bring different legal effects.  
Directives are referred to in a variety of documents from such areas as instruction 
manuals for medical professionals and patients, instructions for use, medical articles, 
brochures, flyers, medical equipment and software, even glossaries and packaging. For 
instance, in documents such as EC Certificate Full Quality Assurance System there is  
a reference to the compliance of the quality system with provisions of Annex II of the 
directive 93/42/EEC.  
It can be safely hypothesised that the MDD, AIMD, or IVDD have encouraged, to 
say the least, many manufacturers of medical devices to acknowledge and recognise the 
significance of languages other than the English language and thus have made them 
understand and appreciate the value and importance of translation and translators in the 
market of today. It is finely reflected in the very wording of the IVD directive: its Article 
4, Section 4 stipulates that “Member States may require the information to be supplied 
pursuant to Annex I, part B, section 8 to be in their official language(s) when a device 
reaches the final user.” Moreover, the MDD in Annex I, Article 13.1, states that “Each 
device must be accompanied by the information needed to use it safely and to identify 
the manufacturer, taking account of the training and knowledge of the potential users.”
Ewa KOCIAŁKOWSKA-OKOSKA, Directives and the Sworn Translator… 
74
That is why accurate, competent, and precise translation is an imperative since potential 
users’ knowledge is vital.  
The Medical Device Directive imposes certain requirements on enterprises in 
order to proceed with documentation processing that is performed in several languages, 
which forces enterprises to provide for the translation of documents. These documents 
are related with instructions for use, labelling, packaging and, if need arises, supporting 
documentation. These materials are very important, especially when we consider 
instructions for use intended for the final user: the safety of application of a medical 
device that is used in compliance with its purpose and works well is of top priority, and 
low-quality incompetent translation can have a detrimental effect.  
The abovementioned product-related information that the sworn translator faces 
can be divided into two categories, namely, professional use and patient use. The user 
information intended for patients (OTC, over-the-counter, relating to products or devices 
that can be bought without a doctor’s prescription) is usually translated into all 
languages spoken on all potentially available markets, and does not have to result from 
any regulatory restrictions. As regards devices for professional use only, information 
pertaining to the safety of application is usually translated since those products are 
complex, and this level of complexity entails the need for the final users to comprehend 
all information items relevant for the proper functioning of a device. Consequently, this 
information is provided in the native language of the user. For that reason, accurate, 
precise and terminologically acceptable translation is absolutely crucial. It must be 
underlined that not only does inappropriate, inaccurate or terminologically inadequate 
translation adversely affect the final user (be it a physician or patient) but also it does 
breach the directive and its provisions. We are not capable of anticipating the legal 
consequences of court proceedings in a case when hypothetically a legal action is 
instigated against a manufacturer, which results from the error made by the user. This 
error may stem from the user’s inability of understanding, e.g., instructions for use in  
a foreign language. The damage to the reputation and business operation of the 
manufacturer would occur anyway, regardless of the potentiality of being liable in legal 
terms.  Therefore, we could say good translation, no matter whether it is legally binding 
a specific manufacturer as to a specific product, is a profitable investment.  
Sworn translators do refer to and consult the translated versions of EU 
instruments in order to remain in line with the versions transposed into their national 
legislations, thus directives are for them one of the sources of relevant and necessary 
information. The terminology, and specific terms in particular, used in directives form 
certain guidelines for translators (notwithstanding some terminological problems). 
Translating medicine-related texts requires from the translator to be knowledgeable 
about the field to the extent available and possible in case of persons who are not 
physicians themselves (or experts from other related fields such as, e.g., pharmacy, 
biology, biochemistry, physiology, etc.). If the translator fails to understand the text – 
and violates the first and most important principle of translation – they will not be able to 
translate it correctly. As obvious as it may seem, there are instances when this 
understanding of the translator’s role is somewhat distorted… In addition to the 
knowledge of the field and specialist terminology, the translator must also have an 
understanding of the context in which a given text functions. The ideal path seems to be 
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the one proposed by O’Neill (1998, 76) when the text is first translated by the translator 
and then verified in terms of substance and terminology compliance by an expert (e.g. a 
physician), or the text is translated by a physician, and then is ‘polished’ in terms of 
stylistics and language by the translator. This seems to be the best, or most effective 
option when it comes to successful and high quality translation of medical texts. 
Specialist knowledge, apart from the translator’s own motivation to develop it, should be 
accompanied by information mining in the form of having access to and using any 
sources of information, starting from specialist dictionaries, glossaries, books, databases, 
articles and online information.  
As stated previously, directives (and MDD in particular, for the purposes of this 
article) are valuable sources of information on the terminology used and  specific 
solutions that may be considered necessary not only by translators themselves, but also 
by either natural persons or corporate bodies commissioning translation tasks. For that 
reason it would be interesting and worthy to have a brief insight into the way the MDD 
is translated into Polish so as to verify whether it can truly be a valuable source of 
information for the sworn translator, or rather its translation should be treated with 
caution. The examples provided in the remainder of the article are taken from the Polish 
translation of the MDD. The subject of assessment are not broadly understood language 
problems (errors, of semantic or syntactic nature, quite a substantial number of which 
can be found in the aforementioned directive and would need separate and further 
research) but only specialist terms as they pose the biggest challenge for translators who 
may be translation experts but are not experts in medicine.  
MDD in translation: a comparison 
To illustrate terminological problems addressed above, examples of specific terms 
occurring in the directive shall be provided. The methodology applied shall be a micro-
comparative study: the study is limited to one instrument only, and only specific 
equivalents used are subject to comparison. It aims at addressing potential translation 
gaps and terminological inconsistencies encountered in the translation of the MDD, 
which will allow us to assess the efficiency of the transfer of terms from one language to 
another. The micro-comparative study is focused on the ways specific medical terms 
were translated into Polish; these terms are extracted from the original and compared 
with their translated equivalents in the Polish version of the directive. As a way of 
signalling terminological problems occurring in the MDD and potential consequences 
both for translators who refer to the MDD as one of information sources and translation 
users, those examples of ‘problematic’ translations in the Polish version of the directive 
shall be briefly discussed, and tentative categorisation of translation inconsistencies shall 
be also presented which reflects the nature of those problems. Numbers of articles and 
sections of the MDD are provided, respectively.  
Example 1: inconsistency
The first example concerns medicinal products: this term is used as early as in the 
preamble to the Directive and occurs quite regularly throughout the entire 
document. In the Polish version medicinal products are inconsistently translated at 
times as produkty lecznicze, but sometimes as leki gotowe. The more relevant 
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option would be the former, since produkty lecznicze in contrast to leki gotowe
cover an entire range of products, and not only medicines or drugs, and thus are 
closer to the meaning range of the English term. This is reflected in the very 
wording of the subsection (Art. 1, Section 5) where medicinal products include also 
products ‘derived from blood as covered by Directive 89/381/EEC’.  
Example 2: omission
In Article 1/ Section 2(c) the words calibrator and control material are missing 
and, quite surprisingly, were not translated into Polish at all: this omission may 
yield grave consequences since no calibration (thus no obligation imposed on the 
manufacturer) can possibly make substantial volume of equipment useless. The 
absence of control material may result in the understanding that no controls or 
control groups are required to perform valid clinical trials in this particular case.   
Example 3: terminology
In Article Section 5(a) in vitro diagnostic devices were translated as wyroby 
diagnostyczne in vitro whereas the usual and most frequently applied term in this 
context is wyroby medyczne do diagnostyki in vitro. The same problem occurs in 
Section  5(e) in  this Article where blood  products were translated into produkty 
z krwi ludzkiej which seems slightly awkward and stylistically deficient, as the 
standard term is produkty krwiopochodne. The same section can also ‘take pride in’ 
two other examples, namely, plasma translated as  plazma ludzka instead of osocze
and yet another problem with blood cells of human origin emerging as komórki 
krwi pochodzenia ludzkiego instead of komórki krwi ludzkiej.  
Example 4: terminology
Article 1 Section 5(f) applies transplanty for transplants where transplanty are 
very rarely used in Polish in this specific context as przeszczepy or przeszczepione 
narzdy are incomparably more common, not to mention the fact that the Polish 
translation sounds stylistically deficient and is not used as a relevant term.  
Example 5: misunderstanding 
In Annex 1, Section II, Subsection 7.2 another serious problem cannot go 
unnoticed as the meaning of the original sentence is distorted due to the translator 
not having properly understood the original. The sentence:  
The devices must be designed, manufactured and packed in such a way as to 
minimize the risk posed by contaminants and residues to the persons involved in 
the transport, storage and use of the devices and to the patients (…)  
was translated into Polish as: 
Wyroby musz by projektowane, produkowane i pakowane w sposób 
minimalizujcy zagroenie powodowane skaeniem i pozostałociami po osobach 
zajmujcych si transportem, przechowywaniem i uywaniem wyrobów oraz po 
pacjentach (…)  
where the term residues is applied to refer to components or ingredients of medical 
devices that can have an adverse effect on the persons involved in transport and on 
the patients. This sentence may be understood as if persons involved in transport as 
well as patients were responsible for contamination and leaving any kind of 
residues  behind, which  obviously is a nonsense.  A better option would  be to use 
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w stosunku do or wobec/ w przypadku osób zajmujcych si transportem (…) oraz 
wobec/ w stosunku do/ w przypadku pacjentów. 
Example 6: terminology
In Annex 1, Section 9, Subsection 9.2 we see the volume/pressure ratio translated 
almost literally as objto/współczynnik cinienia whereas a better, more 
frequently occurring and certainly more context-fitting option would be 
współczynnik ciliwoci since the clause does not refer to general pressure but to 
properties of devices relevant in cases where their application does involve 
pressing the device (or the product) onto e.g. a surgical site (in procedures that 
require the usage of haemostatic materials such as haemostatic sponges, bonewax, 
etc.). These are instances where współczynnik ciliwoci of the product or device 
is essential for the patient’s performance. 
The same subsection ‘houses’ another example similar in nature to transplanty, 
namely, implants were translated into implantaty instead of implanty. This probably 
results from the translator’s misspelling, yet the final effect is not satisfactory, to 
say the least, and the term is not really used in Polish medical texts. 
Example 7: terminology 
Another example that shows certain deficiency in the knowledge of medical 
terminology can be found in Annex IX, Section III, Subsection 2, Rule 5 where the 
ear drum (‘ympanic membrane’ in medical terminology) was translated as 
nabłonek bbenka. From the medical point of view bbenek as a bodily organ does 
not exist; on the humorous side one may venture a conclusion that maybe the 
translator followed młoteczek, kowadełko and strzemiczko (being part of the ear) 
and found bbenek matching with the aforementioned, yet the proper name for this 
part of the human ear is błona bbenkowa and the phrase refers to nabłonek błony 
bbenkowej or simply to błona bbenkowa. 
The findings of the above study corroborate a seemingly obvious truth: while 
translating medical or medicine-related texts the most important factor is the subject 
specialist knowledge, without which the translator  – even understanding words – is not 
capable of comprehending terms included in the text, the textual context and the 
processes, to which a given text refers. This specialist advanced knowledge of the field is 
a substantial determinant both for the process and for the product of translation (and 
translation competence is reflected in the process and the product of translation, which 
has been empirically verified by e., the PACTE group [2009, 209]). The language level 
of those texts is not substantially varied in terms of style, use of register or of complex 
grammatical structures; it is terminology that occurs to be the major ‘enemy’ of the 
translator. 
Concluding remarks 
From the above examples we can explicitly infer that terminological deficiencies and 
inaccuracies in the text substantially affect the perception of the translation. Yet, the 
underlying danger is that those imperfect renderings may adversely affect the quality of 
texts produced by sworn translators. There is an apparent tendency to enter a – once 
translated – phrase or term into a database, and subsequently such term becomes an 
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equivalent that is almost automatically chosen and applied, yet not always verified.  
It seems surprising that even though translation solutions suggested are wrong and faulty 
(or even misspelled), they are still to be found in the texts that – as mentioned above – 
are to serve as a source of reference and information. Undoubtedly, an increasing 
awareness, on the part of sworn translators, as to the possible drawbacks of the translated 
version is a factor facilitating the development of professional experience and 
competence, yet in the long run badly translated – in terms of terminology – legal 
instruments can be even detrimental to the well-being, or even health, of patients or final 
users of medical devices. Thus translators should be more careful and less reliant on the 
directive, and on the reliability of the terms used in the Polish version. This presumably 
should lead to the increasing awareness of the importance of personal professional 
competence, ability to search for and find relevant and credible information in e.g., 
parallel texts, such as papers in medical journals, medical databases. This will also lead 
to demythologisation of directives, whose translated versions are sometimes – 
unfortunately – treated as an invaluable source of truth.  
One of potential remedies to this problem might be a changing role of the sworn 
translator to be more active in the institutional sense: to officially inform on and indicate 
errors, monitor modifications introduced and verify resultant effects through the 
administrative powers of professional associations. Thus, such blunders would not be 
seen in official versions of documents transposed into Polish legal regulations.  
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                                                               EU directives:  
Medical Device Directive (Directive 93/42/EEC of the European Parliament and of the 
Council of 14 June 1993 on medical devices), http://eurlex.europa.eu/ 
LexUriServ/LexUriServ.do?uri=CONSLEG:1993L0042:20071011:en:PDF 
Dyrektywa Rady z dnia 14 czerwca 1993 roku dotyczca wyrobów medycznych 
http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG:1993L0042
:20071011:pl:PDF (DoA: 12.08.2014). 
In Vitro Diagnostics Directive (Directive 98/79/EC of the European Parliament and of 
the Council of 27 October 1998 on in vitro diagnostic medical devices, 
http://eurlex.europa.eu/legalcontent/EN/TXT/HTML/?uri=CELEX:31998L0079&from=en, 
Dyrektywa 98/79/WE z dnia 27 padziernika 1998 roku dotyczca wyrobów 
medycznych do diagnozy in vitro http://eur-lex.europa.eu/legalcontent/PL/TXT 
/HTML/?uri=CELEX:31998L0079&from=en (DoA: 12.08.2014). 
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